Abstract: Neurodegenerattve disorders such as Alzheimer’s and Parkinson’s diseases are increasing in prevalence as world populations age. While tremendous progress has been made, our understanding of the mechanisms that underlie the development of these diseases remains far from complete. More troubling, despite the growing emottonal and ffnancial toll being taken by neurodegenerative disorders, existing treatment opttons are limited almost exclusively to those that help manage symptoms but that lack the ability to alter the progression of the disease (Liu et al., 2022).